Zdrowie i gospodarka · 29/09/2020

FDA Releases Final Guidance on Abbreviated New Drug Application Submissions and Requests for Final Approval

The FDA has released a final guidance to help pharmaceutical companies prepare and submit amendments to tentatively approved abbreviated new drug applications, aiming to facilitate timely final approval and comply with patent and exclusivity protections.